Rani Therapeutics Holdings, Inc. (RANI) Social Stream
RANI THERAPEUTICS HOLDINGS INC (RANI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RANI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-22 | 5 | $29 | $23 | $24.6 | $3.35 | 634.33% |
| 2021-11-23 | 5 | $33 | $23 | $26.6 | $3.35 | 694.03% |
| 2022-03-30 | 5 | $33 | $24 | $28.4 | $3.35 | 747.76% |
| 2022-05-13 | 5 | $32 | $24 | $27.4 | $3.35 | 717.91% |
| 2022-05-16 | 5 | $32 | $24 | $26.6 | $3.35 | 694.03% |
| 2022-06-13 | 6 | $32 | $24 | $26.833 | $3.35 | 700.99% |
| 2022-07-29 | 7 | $32 | $22 | $26.142 | $3.35 | 680.36% |
| 2022-08-10 | 6 | $32 | $22 | $26.142 | $3.35 | 680.36% |
| 2022-08-19 | 7 | $32 | $17 | $24.571 | $3.35 | 633.46% |
| 2022-09-17 | 5 | $32 | $17 | $23.8 | $3.35 | 610.45% |
| 2022-09-29 | 5 | $32 | $19 | $24.2 | $3.35 | 622.39% |
| 2022-11-11 | 6 | $32 | $15 | $22.666 | $3.35 | 576.6% |
| 2022-11-13 | 6 | $32 | $15 | $22.333 | $3.35 | 566.66% |
| 2023-03-23 | 6 | $32 | $15 | $22.5 | $3.35 | 571.64% |
| 2023-03-24 | 6 | $32 | $15 | $22.166 | $3.35 | 561.67% |
| 2023-05-12 | 7 | $32 | $15 | $22.428 | $3.35 | 569.49% |
| 2023-06-06 | 7 | $24 | $15 | $20.666 | $3.35 | 516.9% |
| 2023-07-10 | 7 | $32.001 | $15 | $22.285 | $3.35 | 565.22% |
| 2023-08-13 | 7 | $32 | $15 | $22.285 | $3.35 | 565.22% |
| 2023-08-16 | 7 | $32 | $15 | $22 | $3.35 | 556.72% |
| 2023-09-20 | 6 | $32 | $15 | $21.333 | $3.35 | 536.81% |
| 2023-10-23 | 6 | $32 | $17 | $22.6 | $3.35 | 574.63% |
| 2023-11-02 | 6 | $32 | $10 | $19.8 | $3.35 | 491.04% |
| 2023-11-09 | 7 | $32 | $10 | $19 | $3.35 | 467.16% |
| 2023-11-10 | 7 | $21 | $7 | $13.166 | $3.35 | 293.01% |
The Trend in the Analyst Price Target
Over the past 15 months, RANI's average price target has gone down $10.29.
Over the past 44 weeks, RANI's average upside potential has been 519.31%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-23 | 6 | 32 | 15 | 22.500 | 5.54 | 306.14% |
| 2023-06-06 | 7 | 24 | 15 | 20.666 | 4.93 | 319.19% |
| 2023-08-16 | 7 | 32 | 15 | 22.000 | 4.16 | 428.85% |
| 2023-10-23 | 6 | 32 | 17 | 22.600 | 1.96 | 1053.06% |
| 2023-11-09 | 7 | 32 | 8 | 17.333 | 1.92 | 802.76% |
RANI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 27 months, RANI's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RANI as an investment opportunity.
- RANI THERAPEUTICS HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 2949.41% of all US stocks.
- In the context of all US stocks, RANI THERAPEUTICS HOLDINGS INC's variance in analysts' estimates is lower than -1914.24% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, RANI THERAPEUTICS HOLDINGS INC's number of analysts covering the stock is greater than 2237.5% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, RANI THERAPEUTICS HOLDINGS INC's average analyst price target is greater than 1868.76% of them.
In the Pharmaceutical Products industry, CYBN, VAXX, and GNLX are the three stocks most similar to RANI THERAPEUTICS HOLDINGS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding RANI using the data that counts. Try POWR Ratings for free.